genetic risk assessment test

FDA makes premarket exemption official for genetic risk assessments
By Jonah Comstock | 02:20 pm | June 04, 2018
As of tomorrow, individual genetic risk tests are officially exempt from requiring 510(k) premarket approval, provided the company offering the test has gone through a one-time premarket review of its testing apparatus and at least one test.